Midlife Plasma Aβ and Late-Life Risk of Cognitive Impairment: The Atherosclerosis Risk in Communities Study

Plasma-based biomarkers of amyloid beta (Aβ), a neuropathological hallmark of Alzheimer’s disease, show promise in predicting cognitive impairment and mapping onto cerebral amyloidosis, but little is known about how midlife plasma Aβ associates with late-life cognitive outcomes. Midlife plasma varia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Innov Aging
Autores principales: Sullivan, Kevin, Blackshear, Chad, Sharrett, A Richey, Gottesman, Rebecca, Knopman, David, Windham, B Gwen, Griswold, Michael, Mosley, Thomas
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7740202/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igaa057.810
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares